Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., Columbia University College of Physicians and Surgeons 1985
• 

  Duke Appointment History

  • Instructor Temporary in the Department of Medicine, Medicine, Gastroenterology, Medicine 2010 - 2011
• Research
• 

  Selected Grants

  • Duke Training Grant in Digestive Diseases and Nutrition awarded by National Institutes of Health 1988 - 2021
  • Inhibitors of TrkB Signaling awarded by National Institutes of Health 2019 - 2020
  • Inhibition of Wnt/B-Catenin Signaling in Colorectal Cancer Therapy awarded by National Institutes of Health 2013 - 2019
  • Inhibitors of TrkB Signaling awarded by National Institutes of Health 2016 - 2019
  • Targeting the WNT/beta-catenin pathway in triple negative breast cancer awarded by Department of Defense 2013 - 2017
  • Bone-targeted calcium channel agonists for osteoporosis awarded by UH Harrington Discovery Institute 2015 - 2017
  • Clinical Oncology Research Career Development Program awarded by National Institutes of Health 2009 - 2015
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Wang, Jiangbo, Xiu-Rong Ren, Hailan Piao, Shengli Zhao, Takuya Osada, Richard T. Premont, Robert A. Mook, Michael A. Morse, Herbert Kim Lyerly, and Wei Chen. “Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy..” The Biochemical Journal 476, no. 3 (February 8, 2019): 535–46. https://doi.org/10.1042/bcj20180385.
       Full Text
    • Mook, Robert A., Jiangbo Wang, Xiu-Rong Ren, Hailan Piao, H Kim Lyerly, and Wei Chen. “Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype..” Bioorganic & Medicinal Chemistry Letters 29, no. 2 (January 2019): 317–21. https://doi.org/10.1016/j.bmcl.2018.11.022.
       Full Text
    • Wang, Jiangbo, Robert A. Mook, Xiu-Rong Ren, Qingfu Zhang, Genevieve Jing, Min Lu, Ivan Spasojevic, H Kim Lyerly, David Hsu, and Wei Chen. “Identification of DK419, a potent inhibitor of Wnt/β-catenin signaling and colorectal cancer growth..” Bioorganic & Medicinal Chemistry 26, no. 20 (November 2018): 5435–42. https://doi.org/10.1016/j.bmc.2018.09.016.
       Full Text
    • Chen, Wei, Robert A. Mook, Richard T. Premont, and Jiangbo Wang. “Niclosamide: Beyond an antihelminthic drug..” Cell Signal 41 (January 2018): 89–96. https://doi.org/10.1016/j.cellsig.2017.04.001.
       Full Text  Link to Item
    • Bhattacharyya, Jayanta, Xiu-Rong Ren, Robert A. Mook, Jiangbo Wang, Ivan Spasojevic, Richard T. Premont, Xinghai Li, Ashutosh Chilkoti, and Wei Chen. “Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth..” Nanoscale 9, no. 34 (August 2017): 12709–17. https://doi.org/10.1039/c7nr01973d.
       Full Text
    • Mook, Robert A., Xiu-Rong Ren, Jiangbo Wang, Hailan Piao, Larry S. Barak, H. Kim Lyerly, and Wei Chen. “Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis..” Bioorganic & Medicinal Chemistry 25, no. 6 (March 2017): 1804–16. https://doi.org/10.1016/j.bmc.2017.01.046.
       Full Text
    • Geer Wallace, M Ariel, Do-Yeon Kwon, Douglas H. Weitzel, Chen-Ting Lee, Tesia N. Stephenson, Jen-Tsan Chi, Robert A. Mook, Mark W. Dewhirst, Jiyong Hong, and Michael C. Fitzgerald. “Discovery of Manassantin A Protein Targets Using Large-Scale Protein Folding and Stability Measurements..” J Proteome Res 15, no. 8 (August 5, 2016): 2688–96. https://doi.org/10.1021/acs.jproteome.6b00237.
       Full Text  Link to Item
    • Kanju, Patrick, Yong Chen, Whasil Lee, Michele Yeo, Suk Hee Lee, Joelle Romac, Rafiq Shahid, et al. “Small molecule dual-inhibitors of TRPV4 and TRPA1 for attenuation of inflammation and pain..” Sci Rep 6 (June 1, 2016). https://doi.org/10.1038/srep26894.
       Full Text  Open Access Copy  Link to Item
    • Ren, X. R., J. Wang, T. Osada, R. A. Mook, M. A. Morse, L. S. Barak, H. K. Lyerly, and W. Chen. “Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth..” Breast Cancer Research : Bcr 17, no. 1 (December 2015).
    • Kwon, Do-Yeon, Hye Eun Lee, Douglas H. Weitzel, Kyunghye Park, Sun Hee Lee, Chen-Ting Lee, Tesia N. Stephenson, et al. “Synthesis and Biological Evaluation of Manassantin Analogues for Hypoxia-Inducible Factor 1α Inhibition..” J Med Chem 58, no. 19 (October 8, 2015): 7659–71. https://doi.org/10.1021/acs.jmedchem.5b01220.
       Full Text  Link to Item
    • Mook, Robert A., Jiangbo Wang, Xiu-Rong Ren, Minyong Chen, Ivan Spasojevic, Larry S. Barak, H Kim Lyerly, and Wei Chen. “Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure..” Bioorg Med Chem 23, no. 17 (September 1, 2015): 5829–38. https://doi.org/10.1016/j.bmc.2015.07.001.
       Full Text  Link to Item
    • Mook, Robert A., Minyong Chen, Jiuyi Lu, Larry S. Barak, H Kim Lyerly, and Wei Chen. “Small molecule modulators of Wnt/β-catenin signaling..” Bioorganic & Medicinal Chemistry Letters 23, no. 7 (April 2013): 2187–91. https://doi.org/10.1016/j.bmcl.2013.01.101.
       Full Text
    • Rheault, T. R., J. C. Stellwagen, G. M. Adjabeng, K. R. Hornberger, K. G. Petrov, A. G. Waterson, S. H. Dickerson, et al. “Discovery of dabrafenib: A selective inhibitor of Raf Kinases with antitumor activity against B-Raf-driven tumors.” Acs Medicinal Chemistry Letters 4, no. 3 (March 14, 2013): 358–62. https://doi.org/10.1021/ml4000063.
       Full Text
    • Wang, Jiangbo, Robert A. Mook, Jiuyi Lu, David M. Gooden, Anthony Ribeiro, Anchen Guo, Larry S. Barak, H Kim Lyerly, and Wei Chen. “Identification of a novel Smoothened antagonist that potently suppresses Hedgehog signaling..” Bioorganic & Medicinal Chemistry 20, no. 22 (November 2012): 6751–57. https://doi.org/10.1016/j.bmc.2012.09.030.
       Full Text
    • Wang, Jiangbo, Jiuyi Lu, Robert A. Mook, Min Zhang, Shengli Zhao, Larry S. Barak, Jonathan H. Freedman, H Kim Lyerly, and Wei Chen. “The insecticide synergist piperonyl butoxide inhibits hedgehog signaling: assessing chemical risks..” Toxicological Sciences : An Official Journal of the Society of Toxicology 128, no. 2 (August 2012): 517–23. https://doi.org/10.1093/toxsci/kfs165.
       Full Text
    • Stellwagen, John C., George M. Adjabeng, Marc R. Arnone, Scott H. Dickerson, Chao Han, Keith R. Hornberger, Alastair J. King, et al. “Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup..” Bioorganic & Medicinal Chemistry Letters 21, no. 15 (August 2011): 4436–40. https://doi.org/10.1016/j.bmcl.2011.06.021.
       Full Text
    • Wang, Jiangbo, Larry S. Barak, Robert A. Mook, and Wei Chen. “Glucocorticoid hedgehog agonists in neurogenesis..” Vitamins and Hormones 87 (January 2011): 207–15. https://doi.org/10.1016/b978-0-12-386015-6.00030-5.
       Full Text
    • Wood, Edgar R., Lisa Shewchuk, Anne Hassel, Jim Nichols, Anne T. Truesdale, Danielle Smith, H Luke Carter, et al. “Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptor..” Biochemical Pharmacology 78, no. 12 (December 2009): 1438–47. https://doi.org/10.1016/j.bcp.2009.07.022.
       Full Text
    • Emmitte, K. A., G. M. Adjabeng, C. Webb Andrews, J. G. Badiang Alberti, R. Bambal, S. D. Chamberlain, R. G. Davis-Ward, et al. “Corrigendum to "Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding" [Bioorg. Med. Chem. Lett. 19 (2009) 1694] (DOI:10.1016/j.bmcl.2009.01.094).” Bioorganic and Medicinal Chemistry Letters 19, no. 9 (May 1, 2009). https://doi.org/10.1016/j.bmcl.2009.01.114.
       Full Text
    • Emmitte, Kyle A., George M. Adjabeng, C Webb Andrews, Jennifer G Badiang Alberti, Ramesh Bambal, Stanley D. Chamberlain, Ronda G. Davis-Ward, et al. “Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding..” Bioorganic & Medicinal Chemistry Letters 19, no. 6 (March 2009): 1694–97. https://doi.org/10.1016/j.bmcl.2009.01.094.
       Full Text
    • Emmitte, Kyle A., Brian J. Wilson, Erich W. Baum, Holly K. Emerson, Kevin W. Kuntz, Kristen E. Nailor, James M. Salovich, et al. “Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R)..” Bioorganic & Medicinal Chemistry Letters 19, no. 3 (February 2009): 1004–8. https://doi.org/10.1016/j.bmcl.2008.11.058.
       Full Text
    • Emmitte, Kyle A., C Webb Andrews, Jennifer G. Badiang, Ronda G. Davis-Ward, Hamilton D. Dickson, David H. Drewry, Holly K. Emerson, et al. “Discovery of thiophene inhibitors of polo-like kinase..” Bioorganic & Medicinal Chemistry Letters 19, no. 3 (February 2009): 1018–21. https://doi.org/10.1016/j.bmcl.2008.11.041.
       Full Text
    • Chamberlain, Stanley D., Anikó M. Redman, Joseph W. Wilson, Felix Deanda, J Brad Shotwell, Roseanne Gerding, Huangshu Lei, et al. “Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity..” Bioorganic & Medicinal Chemistry Letters 19, no. 2 (January 2009): 360–64. https://doi.org/10.1016/j.bmcl.2008.11.077.
       Full Text
    • Chamberlain, Stanley D., Joseph W. Wilson, Felix Deanda, Samarjit Patnaik, Anikó M. Redman, Bin Yang, Lisa Shewchuk, et al. “Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: potent inhibitors of the IGF-1R receptor tyrosine kinase..” Bioorganic & Medicinal Chemistry Letters 19, no. 2 (January 2009): 469–73. https://doi.org/10.1016/j.bmcl.2008.11.046.
       Full Text
    • Cheung, M., K. W. Kuntz, M. Pobanz, J. M. Salovich, B. J. Wilson, C. W. Andrews, L. M. Shewchuk, et al. “Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1..” Bioorganic & Medicinal Chemistry Letters 18, no. 23 (December 2008): 6214–17. https://doi.org/10.1016/j.bmcl.2008.09.100.
       Full Text
    • Harris, Philip A., Amogh Boloor, Mui Cheung, Rakesh Kumar, Renae M. Crosby, Ronda G. Davis-Ward, Andrea H. Epperly, et al. “Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor..” J Med Chem 51, no. 15 (August 14, 2008): 4632–40. https://doi.org/10.1021/jm800566m.
       Full Text  Link to Item
    • Lansing, Timothy J., Randy T. McConnell, Derek R. Duckett, Glenn M. Spehar, Victoria B. Knick, Daniel F. Hassler, Nobuhiro Noro, et al. “In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1..” Molecular Cancer Therapeutics 6, no. 2 (February 2007): 450–59. https://doi.org/10.1158/1535-7163.mct-06-0543.
       Full Text
    • Petrov, Kimberly G., Yue-Mei Zhang, Malcolm Carter, G Stuart Cockerill, Scott Dickerson, Cassandra A. Gauthier, Yu Guo, et al. “Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series..” Bioorg Med Chem Lett 16, no. 17 (September 1, 2006): 4686–91. https://doi.org/10.1016/j.bmcl.2006.05.090.
       Full Text  Link to Item
    • Heerdt, Paul M., Richard Kang, Andrew The’, Mir Hashim, Robert J. Mook, and John J. Savarese. “Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs..” Anesthesiology 100, no. 4 (April 2004): 846–51. https://doi.org/10.1097/00000542-200404000-00014.
       Full Text
    • Savarese, John J., Matthew R. Belmont, Mir A. Hashim, Robert A. Mook, Eric E. Boros, Vicente Samano, Sanjay S. Patel, et al. “Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium..” Anesthesiology 100, no. 4 (April 2004): 835–45. https://doi.org/10.1097/00000542-200404000-00013.
       Full Text
    • Boros, Eric E., Vicente Samano, John A. Ray, James B. Thompson, David K. Jung, Istvan Kaldor, Cecilia S. Koble, et al. “Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys..” Journal of Medicinal Chemistry 46, no. 12 (June 2003): 2502–15. https://doi.org/10.1021/jm020574+.
       Full Text
    • Kaldor, I., P. L. Feldman, R. A. Mook, J. A. Ray, V. Samano, A. M. Sefler, J. B. Thompson, B. R. Travis, and E. E. Boros. “Stereocontrolled synthesis of cis-dibenzoquinolizine chlorofumarates: curare-like agents of ultrashort duration..” The Journal of Organic Chemistry 66, no. 10 (May 2001): 3495–3501. https://doi.org/10.1021/jo010032k.
       Full Text
    • Henke, B. R., K. K. Adkison, S. G. Blanchard, L. M. Leesnitzer, R. A. Mook, K. D. Plunket, J. A. Ray, C. Roberson, R. Unwalla, and T. M. Willson. “Synthesis and biological activity of a novel series of indole-derived PPARgamma agonists..” Bioorganic & Medicinal Chemistry Letters 9, no. 23 (December 1999): 3329–34. https://doi.org/10.1016/s0960-894x(99)00603-4.
       Full Text
    • Samano, V., J. A. Ray, J. B. Thompson, R. A. Mook, D. K. Jung, C. S. Koble, M. T. Martin, et al. “Synthesis of ultra-short-acting neuromuscular blocker GW 0430: a remarkably stereo- and regioselective synthesis of mixed tetrahydroisoquinolinium chlorofumarates..” Organic Letters 1, no. 12 (December 1999): 1993–96. https://doi.org/10.1021/ol9911573.
       Full Text
    • Brown, K. K., B. R. Henke, S. G. Blanchard, J. E. Cobb, R. Mook, I. Kaldor, S. A. Kliewer, et al. “A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat..” Diabetes 48, no. 7 (July 1999): 1415–24.
       Link to Item
    • Boros, E. E., E. C. Bigham, G. E. Boswell, J. Mook, S. S. Patel, J. J. Savarese, J. A. Ray, et al. “Erratum: Bis- and mixed-tetrahydroisoquinolinium chlorofumarates: New ultra-short-acting nondepolarizing neuromuscular blockers (Journal of Medicinal Chemistry (1999) 42 (207)).” Journal of Medicinal Chemistry 42, no. 6 (March 25, 1999). https://doi.org/10.1021/jm990060j.
       Full Text
    • Boros, E. E., E. C. Bigham, G. E. Boswell, R. A. Mook, S. S. Patel, J. J. Savarese, J. A. Ray, et al. “Bis- and mixed-tetrahydroisoquinolinium chlorofumarates: new ultra-short-acting nondepolarizing neuromuscular blockers..” Journal of Medicinal Chemistry 42, no. 2 (January 1999): 206–9. https://doi.org/10.1021/jm980597h.
       Full Text
    • Lewis, J. G., K. Y. Lin, A. Kothavale, W. M. Flanagan, M. D. Matteucci, R. B. DePrince, R. A. Mook, R. W. Hendren, and R. W. Wagner. “A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA..” Proc Natl Acad Sci U S A 93, no. 8 (April 16, 1996): 3176–81. https://doi.org/10.1073/pnas.93.8.3176.
       Full Text  Link to Item
    • Tian, G., R. A. Mook, M. L. Moss, and S. V. Frye. “Mechanism of time-dependent inhibition of 5 alpha-reductases by delta 1-4-azasteroids: toward perfection of rates of time-dependent inhibition by using ligand-binding energies..” Biochemistry 34, no. 41 (October 1995): 13453–59. https://doi.org/10.1021/bi00041a024.
       Full Text
    • Mook, R. A., K. Lackey, and C. Bennett. “Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase.” Tetrahedron Letters 36, no. 23 (June 5, 1995): 3969–72. https://doi.org/10.1016/0040-4039(95)00690-E.
       Full Text
    • Frye, S. V., C. D. Haffner, P. R. Maloney, R. A. Mook, G. F. Dorsey, R. N. Hiner, C. M. Cribbs, T. N. Wheeler, J. A. Ray, and R. C. Andrews. “6-Azasteroids: structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase..” Journal of Medicinal Chemistry 37, no. 15 (July 1994): 2352–60. https://doi.org/10.1021/jm00041a014.
       Full Text
    • Frye, S. V., C. D. Haffner, P. R. Maloney, R. A. Mook, G. F. Dorsey, R. N. Hiner, K. W. Batchelor, H. N. Bramson, J. D. Stuart, and S. L. Schweiker. “6-Azasteroids: potent dual inhibitors of human type 1 and 2 steroid 5 alpha-reductase..” Journal of Medicinal Chemistry 36, no. 26 (December 1993): 4313–15. https://doi.org/10.1021/jm00078a022.
       Full Text
    • Mook, R. A. “Purification of trifluoroacetic anhydride [1].” Chemical and Engineering News 65, no. 13 (December 1, 1987).
    • Stork, G., and R. Mook. “Vinyl Radical Cyclizations Mediated by the Addition of Stannyl Radicals to Triple Bonds.” Journal of the American Chemical Society 109, no. 9 (April 1, 1987): 2829–31. https://doi.org/10.1021/ja00243a049.
       Full Text
    • Stork, G., and R. Mook. “Five vs six membered ring formation in the vinyl radical cyclization.” Tetrahedron Letters 27, no. 38 (January 1, 1986): 4529–32. https://doi.org/10.1016/S0040-4039(00)84995-3.
       Full Text
    • Stork, G., R. Mook, S. A. Biller, and S. D. Rychnovsky. “Free-Radical Cyclization of Bromoacetals. Use in the Construction of Bicyclic Acetals and Lactones.” Journal of the American Chemical Society 105, no. 11 (January 1, 1983): 3741–42. https://doi.org/10.1021/ja00349a082.
       Full Text
    • Stork, G., and R. Mook. “Vinyl Radical Cyclization. 2. Dicyclization via Selective Formation of Unsaturated Vinyl Radicals by Intramolecular Addition to Triple Bonds. Applications to the Synthesis of Butenolides and Furans.” Journal of the American Chemical Society 105, no. 11 (January 1, 1983): 3720–22. https://doi.org/10.1021/ja00349a067.
       Full Text
    • Henke, B. R., S. G. Blanchard, M. F. Brackeen, K. K. Brown, J. E. Cobb, J. L. Collins, W. W. Harrington, et al. “N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents..” J Med Chem 41, no. 25 (December 3, 1998): 5020–36. https://doi.org/10.1021/jm9804127.
       Full Text  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.